[Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
Valenta
R
R
D000485:Allergens / Q000494:pharmacology / Q000627:therapeutic use*; D003888:Desensitization, Immunologic / Q000379:methods* / Q000639:trends*; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D014614:Vaccines, Synthetic / Q000627:therapeutic use*
D000485:Allergens; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic
Rekombinante Allergene: Allergie-Impfstoff der Zukunft?